Organization
UCLA Medical Center, Santa Monica, CA
1 abstract
Abstract
Efficacy and safety of elranatamab in patients with high-risk relapsed/refractory multiple myeloma (RRMM): A subgroup analysis from MagnetisMM-3.Org: UCLA Medical Center, Santa Monica, CA, Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada, Baylor University Medical Center, Dallas, TX, Service d’Hématologie Clinique, Centre Hospitalier Lyon Sud, Pierre-Bénite, France, Fox Chase Cancer Center, Philadelphia, PA,